Search

Fabrazyme

Fabrazyme

agalsidase beta

Manufacturer:

Genzyme

Distributor:

DKSH
Concise Prescribing Info
Contents
Agalsidase β
Indications/Uses
Fabry disease. Reduction of globotriaosylceramide (GL-3) deposition in capillary endothelium of kidney & certain other cell types.
Click to view Fabrazyme detailed prescribing information
Dosage/Direction for Use
1 mg/kg IV infusion every 2 wk.
Click to view Fabrazyme detailed prescribing information
Overdosage
View Fabrazyme overdosage for action to be taken in the event of an overdose.
Warnings
For additional cautionary notes to warn of the potential risk of using the medicine... Click to view Fabrazyme detailed prescribing information
Special Precautions
Life-threatening anaphylactic & severe allergic reactions. Infusion reactions. Closely monitor patients w/ compromised cardiac function. Immunogenicity. Appropriate medical support should be readily available. Pregnancy & lactation.
Click to view Fabrazyme detailed prescribing information
Adverse Reactions
Anaphylactic & allergic reactions. Infusion reactions, chills, pyrexia, feeling hot or cold, dyspnea, nausea, flushing, headache, vomiting, paresthesia, fatigue, pruritus, pain in extremity, HTN, chest pain, throat tightness, abdominal pain, dizziness, tachycardia, nasal congestion, diarrhea, peripheral edema, myalgia, back pain, pallor, bradycardia, urticaria, hypotension, face edema, rash, somnolence. Stroke, pain, ataxia, cardiac arrhythmia & arrest, decreased cardiac output, vertigo, hypoacousia, nephrotic syndrome. Immunogenicity.
Click to view Fabrazyme detailed prescribing information
Caution For Usage
For caution against possible variation of physical aspect of medicine... Click to view Fabrazyme detailed prescribing information
Storage
View Fabrazyme storage conditions for details to ensure optimal shelf-life.
Description
View Fabrazyme description for details of the chemical structure and excipients (inactive components).
Action
View Fabrazyme mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Other Agents Affecting Metabolism
ATC Classification
A16AB04 - agalsidase beta ; Belongs to the class of enzymes. Used in the treatment of alimentary tract and metabolism problems.
Presentation/Packing
Form
Fabrazyme powd for infusion 35 mg
Packing/Price
(single-use) 1's
Form
Fabrazyme powd for infusion 5 mg
Packing/Price
(single-use) 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in